Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank33
3Y CAGR+0.6%
5Y CAGR-51.9%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+0.6%/yr
Annual compound
5Y CAGR
-51.9%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.18 | +128.1% |
| 2024 | 1.83 | -82.1% |
| 2023 | 10.24 | +149.5% |
| 2022 | 4.11 | -86.3% |
| 2021 | 30.04 | -81.5% |
| 2020 | 162.40 | -21.1% |
| 2019 | 205.78 | - |